bpV(phen) (potassium hydrate)
| 中文名称 | bpV(phen) (potassium hydrate) |
|---|---|
| 中文同义词 | |
| 英文名称 | bpV(phen) (potassium hydrate) |
| 英文同义词 | bpV(phen) (potassium hydrate);Bisperoxovanadium (Bisperoxovanadium(phen);bpV(phen) trihydrate |
| CAS号 | 171202-16-7 |
| 分子式 | C12H10KN2O6V |
| 分子量 | 368.26 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 171202-16-7.mol |
| 结构式 |  |
bpV(phen) (potassium hydrate) 性质
| 储存条件 | Store at -20°C |
|---|---|
| 溶解度 | DMSO：1mg/mL； PBS（pH 7.2）：10 mg/mL |
| 形态 | 结晶固体 |
| 颜色 | 黄至橙色 |
IC50: 38 nM (PTEN), 343 nM (PTP-β) and 920 nM (PTP-1B)
Parasite
Leishmania
Apoptosis
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment causes a further decrease of cell viability in H/R-injured H9c2 cells.
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment increases the apoptosis of H/R-injured H9c2 cells.
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment significantly promotes the accumulation of cytoplasmic Cytochrome C in H/R-injured H9c2 cells.
After stimulation of bpV(phen), PTEN-induced putative kinase protein 1 (PINK1)/Parkin-mediated mitophagy is inhibited.
bpV(phen) is an insulin-mimetic agent following insulin-receptor tyrosine kinase hyperphosphorylation and activation.
Cell Viability Assay
| Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells |
| Concentration: | 5 μM |
| Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) |
| Result: | Caused a further decrease of cell viability. |
Apoptosis Analysis
| Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells |
| Concentration: | 5 μM |
| Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) |
| Result: | Increased the apoptosis of H/R-injured H9c2 cells. |
Western Blot Analysis
| Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells |
| Concentration: | 5 μM |
| Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) |
| Result: | Showed an increased release of Cytochrome C. |
bpV(phen) (5 mg/kg; intraperitoneal injection; daily; for 38 days; male BALB/c nude (nu/nu) athymic mice) treatment causes a significant reduction in average tumor volume.
| Animal Model: | Male BALB/c nude (nu/nu) athymic mice (6-7 weeks old) injected with PC-3 cells |
| Dosage: | 5 mg/kg |
| Administration: | Intraperitoneal injection; daily; for 38 days |
| Result: | Caused a significant reduction in average tumor volume. |
安全信息
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024/04/30 | HY-122818 | bpV(phen) (potassium hydrate) bpV(phen) trihydrate | 171202-16-7 | 5mg | 650元 |
| 2024/04/30 | HY-122818 | bpV(phen) (potassium hydrate) bpV(phen) trihydrate | 171202-16-7 | 10mg | 1050元 |